Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Colby who wrote (18854)	2/17/1999 6:14:00 PM
From: VLAD	Respond to of 23519

Colby, I think this is the second time this company released the same hype news release to promote their snake oil. Here we go....back to rhino horn and tiger penis bone. I bet more money is made on voodoo medicine for ED than all prescription meds combined. Too bad people are so stupid. bit if the problem is in their head and they believe it works, it WILL work. More power to them....I guess.

To: Colby who wrote (18854)	2/17/1999 6:20:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

Here is some information about the Astra/Zeneca merger: rd.yahoo.com*http:/cbs.marketwatch.com/archive/19990217/news/current/zen.htx?source=blq/yhoo&dist=yhoo Apparently for the merger to be finalized, Zeneca shareholders will vote tomorrow and Astra shareholders a month from tomorrow on March 18. I wonder why there is a one month difference for the 2 companies to conduct shareholder votes??? I believe us Vivus peons should keep a close watch on how smoothly this transition occurs. The sooner it is finalized the better it will be for the merged company to focus on what it was designed to do--sell drugs including MUSE in Europe, South America, Australia/New Zealand and hopefully the USA!